(Q80209074)
Statements
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies (English)
Karen W L Yee
Zhihong Zeng
Marina Konopleva
Farhad Ravandi
Alessandra Ferrajoli
Deborah Thomas
William Wierda
Efrosyni Apostolidou
Susan O'Brien
Michael Andreeff
Francis J Giles
1 September 2006